BPC-157 + TB-500 Blend
Free Priority Shipping on Orders $99+
The BPC-157 + TB-500 Blend is a combined research formulation containing two distinct synthetic peptides: the pentadecapeptide BPC-157 and the 43-amino acid peptide TB-500 (Thymosin Beta-4). This blend is designed to investigate the potential synergistic effects of simultaneous exposure to these compounds, specifically focusing on the intersection of angiogenesis (new blood vessel formation) and cytoskeletal actin regulation in cellular models.
For Research Use Only. Not for human consumption.
$115.00
In stock
In stock
This product comprises a stoichiometric blend of BPC-157 (C₆₂H₉₈N₁₆O₂₂), a partial sequence of the body protection compound, and TB-500 (C₂₁₂H₃₅₀N₅₆O₇₈S), a synthetic analogue of the naturally occurring protein Thymosin Beta-4. The combination allows researchers to study dual mechanisms of action within a single experimental setup, comparing the efficacy of co-administration versus individual peptide application in tissue culture models.
BPC-157 is primarily investigated for its interaction with the nitric oxide (NO) system and the modulation of growth factors such as VEGF (Vascular Endothelial Growth Factor). It is observed in laboratory settings to influence fibroblast survival and the organization of collagen during the early stages of cellular repair. Researchers utilize this component to understand the biochemical pathways governing soft tissue integrity and gastric mucosal stability.
TB-500 functions through a distinct mechanism involving the sequestration of G-actin. By regulating actin polymerization, TB-500 is critical for maintaining cytoskeletal structure and facilitating cell migration. Scientific studies explore how this peptide influences the mobility of keratinocytes and endothelial cells, which is a necessary step in the re-epithelialization of damaged tissue matrices.
The simultaneous presence of both peptides in this blend serves as a tool for examining the convergence of vascular support and cellular mobility. Current research hypothesizes that the angiogenic properties of BPC-157 may complement the cell-migration promoting activities of TB-500, potentially accelerating recovery parameters in models of musculoskeletal injury and inflammation.
This product is strictly for laboratory and research purposes only. The BPC-157 + TB-500 Blend is not intended for human use, diagnostic, or therapeutic procedures. It serves as a reagent for scientific study and method development.
References
- Sikiric, P., et al. (2010). “Focus on BPC 157.” Current Pharmaceutical Design, 16(10), 1224-1234.
- Philp, D., et al. (2004). “Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development.” Mechanisms of Ageing and Development, 125(2), 113-115.
- Chang, C. H., et al. (2011). “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of Applied Physiology, 110(3), 774-780.
